CAS 182945-56-8 β Amyloid(28-35) Human

Send Inquiry
CAS 182945-56-8 β Amyloid(28-35) Human
Details
Human Aβ residues 28-35;
Category: Aβ transition-region peptide / folding model.
Peptide Purity (HPLC) ≥95%
CAS No. 182945-56-8
Structure Linear 8-mer (human Aβ28-35)
Solubility Readily soluble in water/PBS
Storage Powder, −20°C, dry, light-protected
Category
Beta-Amyloid Peptides
Share to
Description

Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of cas 182945-56-8 β amyloid(28-35) human in China, also supports custom service. Welcome to wholesale bulk high quality cas 182945-56-8 β amyloid(28-35) human from our factory. Contact us for more details.

 

Description Spans Lys28 (salt-bridge partner) through GSNKGAI toward the hydrophobic C-terminus; used to study the transition segment linking the central region to the C-terminal core in fibril formation.

 

Product Basic Information Table

 

Standard English Name Abbreviations/Aliases Functional Tags Structural Core Molecular Formula Exact MW (Da) Average MW (Da) Salt Form Length (aa)
β-Amyloid (28-35), human Aβ28-35; Amyloid-β 28-35; KGAIIGLM; CAS 182945-56-8 Aβ C-terminal short fragment, neurotoxicity model, membrane interaction, Met oxidation-prone, aggregation study 8-mer, sequence KGAIIGLM; the Aβ C-terminal 28-35 fragment containing Met35; free N-terminus and C-terminus; short and weakly aggregating; C-terminal hydrophobic IGLM and Met35 participate in membrane insertion and neurotoxicity; Met35 readily oxidizes to MetO35 with loss of toxicity, requiring oxygen-free storage. C36H67N9O9S 801.48 802.05 TFA salt / powder 8

 

Physicochemical Solubility & Storage Parameters

 

Product Code Appearance Long-term Storage Short-term Storage Solution Stability Solid Stability
PEP-AB2835-01 White to off-white powder -20°C, sealed, dry, light-protected, aliquots; ~2 years. Met-containing peptides require inert-gas (Ar/N2) headspace to prevent oxidation 2-8°C for ~1 week; working aliquots stored at -20°C, avoid repeated freeze-thaw Good aqueous solubility; reconstitute directly in sterile water or buffer. Because of the oxidation-prone Met35, prepare working solutions fresh, keep under Ar/N2 headspace and use promptly to avoid oxidation to methionine sulfoxide (MetO35), which abolishes neurotoxicity. solid stable ~2 years at -20°C, dry and sealed. Because it contains Met35, the vial must be kept under inert-gas (Ar/N2) headspace, protected from light, both before and after opening; equilibrate to RT in a desiccator before weighing to prevent moisture uptake and oxidation.

 

Functional Description

 

Product Code Short Summary (listing) Detailed Biological Function Research Areas Targets/Receptors
PEP-AB2835-01 Human Aβ(28-35) octapeptide KGAIIGLM (CAS 182945-56-8), an Aβ C-terminal short fragment containing the key residue Met35. A classic short-peptide model for Aβ C-terminal neurotoxicity, membrane interaction and redox studies; weakly aggregating 8-mer with oxidation-prone Met requiring inert-gas storage. Aβ(28-35), KGAIIGLM, is one of the most neurotoxic short functional fragments at the C-terminus of Aβ. Despite only 8 residues, it retains the C-terminal hydrophobic core and the critical Met35 residue. Aβ28-35 is reported to insert into membranes, perturb calcium homeostasis, induce reactive oxygen species (ROS) and cause mitochondrial damage, making it a widely used short-peptide tool for in vitro neurotoxicity models. Its toxicity strongly depends on the reduced state of Met35: oxidation of Met35 to methionine sulfoxide (MetO35) markedly reduces membrane disruption and neurotoxicity, and the redox state of Met35 is therefore regarded as a key switch regulating Aβ toxicity. This peptide aggregates less than full-length Aβ and has good aqueous solubility, suitable for: membrane interaction / ion-channel formation, oxidative stress and mitochondrial toxicity, calcium-signaling dysregulation, and structure-activity studies of Met oxidation. Because Met35 is highly oxidation-prone, the product must be stored under inert gas, protected from light, and working solutions should be prepared fresh. Alzheimer's disease (AD) neurotoxicity, Aβ C-terminal fragment, membrane interaction / ion channels, oxidative stress / ROS, Met redox structure-activity, short-peptide toxicity model Cell membrane / lipid bilayer; Met35 redox; calcium-channel / mitochondrial ROS pathways

 

 

 

 

Hot Tags: cas 182945-56-8 β amyloid(28-35) human, China cas 182945-56-8 β amyloid(28-35) human manufacturers, suppliers, factory, Amyloid 1 11 , Amyloid 1 28 , Amyloid 1 8 , 152286-31-2, 659739-33-0, CAS 190436 05 6

Send Inquiry